Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 16;41(21):3712–3723. doi: 10.1200/JCO.22.02459

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by American Society of Clinical Oncology

PMC Copyright notice

FIG 2. — Safety profiles and activity of ICIs among PWH. (A) irAEs by type; cumulative incidence of irAEs among (B) CD4+ T-cell counts and (C) CD4:CD8 ratio subgroups; and (D) ORR across top 10 cancer types. HCC, hepatocellular carcinoma; HL, Hodgkin lymphoma; HNSCC, head and neck squamous cell carcinoma; ICI, immune checkpoint inhibitor; irAEs, immune-related adverse events; KS, Kaposi sarcoma; NHL, non-Hodgkin lymphoma; NSCLC, non–small-cell lung cancer; ORR, objective response rate; PWH, people living with HIV; SCLC, small-cell lung cancer.